Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model

Hamed Zare ¹ , Hamid Bakherad ^2,3 * , Arman Nasr Esfahani ², Mohamad Norouzi ², Hossein Aghamollaei ⁴, Seyed Latif Mousavi Gargari ⁵, Fatemeh Mahmoodi ⁶, Mahdi Aliomrani ⁷, Walead Ebrahimizadeh ⁸

Cited by CrossRef: 2

1- Herrera-Quintana L, Vázquez-Lorente H, Plaza-Diaz J. Breast Cancer: Extracellular Matrix and Microbiome Interactions. IJMS. 2024;25(13):7226 [Crossref]

2- Yang Y, Li W, Zhao Y, Sun M, Xing F, Yang J, Zhou Y. GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches. Biomedicines. 2025;13(2):382 [Crossref]

3- Bhamidipati P, Nagaraju G, Malla R. Immunoglobulin-binding protein and Toll-like receptors in immune landscape of breast cancer. Life Sciences. 2024;358:123196 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons